Cannabidiol Cleared for Tuberous Sclerosis Complex in Europe Cannabidiol Cleared for Tuberous Sclerosis Complex in Europe

The European Commission has approved cannabidiol for seizures associated with tuberous sclerosis complex in patients aged 2 years and older, marking the third indication in Europe.International Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news